The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Zweemer, 2014, Bias in chemokine receptor signalling, Trends Immunol., 35, 243, 10.1016/j.it.2014.02.004
Proudfoot, 2002, Chemokine receptors: multifaceted therapeutic targets, Nat Rev Immunol., 2, 106, 10.1038/nri722
Stoolman, 1989, Adhesion molecules controlling lymphocyte migration, Cell, 56, 907, 10.1016/0092-8674(89)90620-X
Luster, 1998, Chemokines–chemotactic cytokines that mediate inflammation, N Engl J Med., 338, 436, 10.1056/NEJM199802123380706
Koch, 2005, Chemokines and their receptors in rheumatoid arthritis: future targets?, Arthr Rheum, 52, 710, 10.1002/art.20932
Yellin, 2012, A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis, Arthritis Rheum, 64, 1730, 10.1002/art.34330
Mcguire, 2011, A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity, Immunity, 34, 602, 10.1016/j.immuni.2011.01.021
Frigerio, 2002, Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis, Nat Med., 8, 1414, 10.1038/nm1202-792
Shehadeh, 2009, Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis, J Immunol., 182, 8104, 10.4049/jimmunol.0803348
Antonelli, 2008, High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis, Autoimmunity, 41, 537, 10.1080/08916930802170401
Harper, 2009, Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis, J Invest Dermatol., 129, 2175, 10.1038/jid.2009.65
Samama, 1993, A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model, J Biol Chem., 268, 4625, 10.1016/S0021-9258(18)53442-6
Reiter, 2012, Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors, Annu Rev Pharmacol Toxicol., 52, 179, 10.1146/annurev.pharmtox.010909.105800
Reboldi, 2009, C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nat Immunol., 10, 514, 10.1038/ni.1716
Karin, 2015, Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets, J Leukoc Biol, 99, 857, 10.1189/jlb.2MR0915-441R
Meiron, 2008, CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells, J Exp Med., 205, 2643, 10.1084/jem.20080730
Wildbaum, 2002, Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis, J Immunol., 168, 5885, 10.4049/jimmunol.168.11.5885
Groom, 2011, CXCR3 ligands: redundant, collaborative and antagonistic functions, Immunol Cell Biol., 89, 207, 10.1038/icb.2010.158
Tokunaga, 2018, CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy, Cancer Treat Rev., 63, 40, 10.1016/j.ctrv.2017.11.007
Kato, 2018, CXCR3(high) CD8+ T cells with naïve phenotype and high capacity for IFN-γ production are generated during homeostatic T-cell proliferation, Eur J Immunol., 10.1002/eji.201747431.
Metzemaekers, 2017, Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands, Front Immunol., 8, 1970, 10.3389/fimmu.2017.01970
Loetscher, 1996, Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes, J Exp Med., 184, 963, 10.1084/jem.184.3.963
Lasagni, 2003, An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4, J Exp Med., 197, 1537, 10.1084/jem.20021897
Ehlert, 2004, Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping, J Immunol., 173, 6234, 10.4049/jimmunol.173.10.6234
Berchiche, 2016, CXC chemokine receptor 3 alternative splice variants selectively activate different signaling pathways, Mol Pharmacol., 90, 483, 10.1124/mol.116.105502
Qin, 1998, The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions, J Clin Invest., 101, 746, 10.1172/JCI1422
Sallusto, 1998, Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes, J Exp Med., 187, 875, 10.1084/jem.187.6.875
Xanthou, 2003, CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11, Eur J Immunol., 33, 2241, 10.1002/eji.200323787
Khan, 2000, IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection, Immunity, 12, 483, 10.1016/S1074-7613(00)80200-9
Xie, 2003, Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation, J Leukoc Biol., 73, 771, 10.1189/jlb.1102573
Campanella, 2008, Development of a novel chemokine-mediated in vivo T cell recruitment assay, J Immunol Methods, 331, 127, 10.1016/j.jim.2007.12.002
Villarroel, 2014, CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease, J Invest Dermatol., 134, 1552, 10.1038/jid.2014.2
Martin-Fontecha, 2004, Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming, Nat Immunol., 5, 1260, 10.1038/ni1138
Lord, 2005, T-bet is required for optimal proinflammatory CD4+ T-cell trafficking, Blood, 106, 3432, 10.1182/blood-2005-04-1393
Koch, 2009, The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation, Nat Immunol., 10, 595, 10.1038/ni.1731
Littringer, 2018, Common Features of regulatory T cell specialization during Th1 responses, Front Immunol., 9, 1344, 10.3389/fimmu.2018.01344
Lacotte, 2009, CXCR3, inflammation, and autoimmune diseases, Ann NY Acad Sci., 1173, 310, 10.1111/j.1749-6632.2009.04813.x
Antonelli, 2014, Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases, Autoimmun Rev., 13, 272, 10.1016/j.autrev.2013.10.010
Karin, 2018, Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity, Cytokine, 109, 24, 10.1016/j.cyto.2018.02.012
Angiolillo, 1995, Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo, J Exp Med., 182, 155, 10.1084/jem.182.1.155
Romagnani, 2001, Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity, J Clin Invest., 107, 53, 10.1172/JCI9775
Cambien, 2009, Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism, Br J Cancer, 100, 1755, 10.1038/sj.bjc.6605078
Yang, 2016, CXCR3A contributes to the invasion and metastasis of gastric cancer cells, Oncol Rep., 36, 1686, 10.3892/or.2016.4953
Cole, 1998, Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3, J Exp Med., 187, 2009, 10.1084/jem.187.12.2009
Medoff, 2006, CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function, J Immunol., 176, 7087, 10.4049/jimmunol.176.11.7087
Zohar, 2014, CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis, J Clin Invest., 124, 2009, 10.1172/JCI71951
Karin, 2018, Chemokines and cancer: new immune checkpoints for cancer therapy, Curr Opin Immunol., 51, 140, 10.1016/j.coi.2018.03.004
Thapa, 2008, CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system, J Immunol., 180, 1098, 10.4049/jimmunol.180.2.1098
Rosenblum, 2010, CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors, J Immunol., 184, 3450, 10.4049/jimmunol.0903831
Wang, 2013, miRNA-21 inhibition enhances RANTES and IP-10 release in MCF-7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration, Biochem Biophys Res Commun., 439, 384, 10.1016/j.bbrc.2013.08.072
Ratushny, 2012, From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma, J Clin Invest., 122, 464, 10.1172/JCI57415
Liu, 2016, MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10, Clin Immunol., 164, 106, 10.1016/j.clim.2015.12.009
Imaizumi, 2010, IFN-gamma and TNF-alpha synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells, Am J Nephrol., 32, 462, 10.1159/000321365
Terlou, 2012, An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155, J Invest Dermatol., 132, 658, 10.1038/jid.2011.369
Zhang, 2018, MicroRNA-17-92 cluster promotes the proliferation and the chemokine production of keratinocytes: implication for the pathogenesis of psoriasis, Cell Death Dis., 9, 567, 10.1038/s41419-018-0621-y
Girardi, 2007, Cutaneous perspectives on adaptive immunity, Clin Rev Allergy Immunol., 33, 4, 10.1007/s12016-007-0040-9
Gebhardt, 2018, Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance, Immunol Rev., 283, 54, 10.1111/imr.12650
Tan, 2015, The role of chemokines in cutaneous immunosurveillance, Immunol Cell Biol., 93, 337, 10.1038/icb.2015.16
Zaid, 2017, Chemokine receptor-dependent control of skin tissue-resident memory T cell formation, J Immunol., 199, 2451, 10.4049/jimmunol.1700571
Alanio, 2018, CXCR3/CXCL10 axis shapes tissue distribution of memory phenotype CD8+ T cells in nonimmunized mice, J Immunol., 200, 139, 10.4049/jimmunol.1700564
Kunkel, 2002, Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes, Am J Pathol., 160, 347, 10.1016/S0002-9440(10)64378-7
Flier, 2001, Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation, J Pathol., 194, 398, 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S
D'ambrosio, 2002, Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion, J Immunol., 169, 2303, 10.4049/jimmunol.169.5.2303
Lazarski, 2013, IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance, PLoS ONE, 8, e71949, 10.1371/journal.pone.0071949
Villagomez, 2004, Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis, Br J Dermatol., 150, 910, 10.1111/j.1365-2133.2004.05937.x
Buttmann, 2005, Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction, J Neuroimmunol., 168, 175, 10.1016/j.jneuroim.2005.07.011
Dai, 2016, CXCR3 blockade inhibits T cell migration into the skin and prevents development of Alopecia Areata, J Immunol., 197, 1089, 10.4049/jimmunol.1501798
Ito, 2013, CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase, J Dermatol Sci., 69, 140, 10.1016/j.jdermsci.2012.12.003
Lowes, 2014, Immunology of psoriasis, Annu Rev Immunol., 32, 227, 10.1146/annurev-immunol-032713-120225
Witte, 2016, Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration, J Mol Med., 94, 391, 10.1007/s00109-015-1367-y
Ottaviani, 2006, CD56brightCD16(–) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation, Eur J Immunol., 36, 118, 10.1002/eji.200535243
Chen, 2010, Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions, Arch Dermatol Res., 302, 113, 10.1007/s00403-009-0966-2
Teraki, 2004, Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris, Clin Exp Dermatol., 29, 658, 10.1111/j.1365-2230.2004.01638.x
Yang, 2018, Role of chemokines and the corresponding receptors in vitiligo: a pilot study, J Dermatol., 45, 31, 10.1111/1346-8138.14004
Boniface, 2018, Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3, J Invest Dermatol., 138, 355, 10.1016/j.jid.2017.08.038
Larsabal, 2017, Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo, J Am Acad Dermatol., 76, 863, 10.1016/j.jaad.2016.10.044
Rashighi, 2014, CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo, Sci Transl Med., 6, 223ra223, 10.1126/scitranslmed.3007811
Richmond, 2017, CXCR3 depleting antibodies prevent and reverse vitiligo in mice, J Invest Dermatol., 137, 982, 10.1016/j.jid.2016.10.048
Meller, 2005, Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus, Arthr Rheum, 52, 1504, 10.1002/art.21034
Wenzel, 2007, Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches, Exp Dermatol., 16, 454, 10.1111/j.1600-0625.2007.00556.x
Ribero, 2017, The cutaneous spectrum of lupus erythematosus, Clin Rev Allergy Immunol., 53, 291, 10.1007/s12016-017-8627-2
Rabquer, 2011, Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis, Arthr Res Ther., 13, R18, 10.1186/ar3242
Kakinuma, 2003, High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid, Br J Dermatol., 148, 203, 10.1046/j.1365-2133.2003.05066.x
Wenzel, 2006, Type I interferon-associated cytotoxic inflammation in lichen planus, J Cutan Pathol., 33, 672, 10.1111/j.1600-0560.2006.00527.x
Wenzel, 2006, Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis, Clin Exp Dermatol., 31, 576, 10.1111/j.1365-2230.2006.02150.x
Wenzel, 2008, An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”, J Invest Dermatol., 128, 2392, 10.1038/jid.2008.96
Piper, 2007, CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation, Blood, 110, 3827, 10.1182/blood-2006-12-061408
Croudace, 2012, Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD, Blood, 120, 4246, 10.1182/blood-2012-02-413260
Jiankuo, 2003, Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft, J Immunol., 170, 1556, 10.4049/jimmunol.170.3.1556
Li, 2010, I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft, Cell Immunol., 260, 83, 10.1016/j.cellimm.2009.09.004
Yates, 2007, Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor, Am J Pathol., 171, 484, 10.2353/ajpath.2007.061092
Yates, 2012, Transplanted fibroblasts prevents dysfunctional repair in a murine CXCR3-deficient scarring model, Cell Transplant., 21, 919, 10.3727/096368911X623817
Yates, 2008, ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair, Am J Pathol., 173, 643, 10.2353/ajpath.2008.070990
Huen, 2012, The beginning of the end: CXCR3 signaling in late-stage wound healing, Adv Wound Care, 1, 244, 10.1089/wound.2011.0355
Kroeze, 2012, Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3, J Invest Dermatol., 132, 216, 10.1038/jid.2011.245
Ariotti, 2015, Subtle CXCR3-dependent chemotaxis of CTLs within infected tissue allows efficient target localization, J Immunol., 195, 5285, 10.4049/jimmunol.1500853
Hensel, 2017, Selective expression of CCR10 and CXCR3 by circulating human herpes simplex virus-specific CD8 T cells, J Virol., 91, e00810, 10.1128/JVI.00810-17
Hickman, 2015, CXCR3 chemokine receptor enables local CD8+ T cell migration for the destruction of virus-infected cells, Immunity, 42, 524, 10.1016/j.immuni.2015.02.009
Geiger, 2010, Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells, Br J Dermatol., 162, 870, 10.1111/j.1365-2133.2009.09573.x
Glennie, 2015, Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection, J Exp Med., 212, 1405, 10.1084/jem.20142101
Lai, 2018, Epidemiology of skin cancer in the mature patient, Clin Dermatol., 36, 167, 10.1016/j.clindermatol.2017.10.008
Mullins, 2004, CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease, Cancer Res., 64, 7697, 10.1158/0008-5472.CAN-04-2059
Mikucki, 2015, Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints, Nat Commun., 6, 7458, 10.1038/ncomms8458
Wenzel, 2005, Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions, Am J Clin Pathol., 124, 37, 10.1309/4EJ9KL7CGDENVVLE
Woo, 2014, STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors, Immunity, 41, 830, 10.1016/j.immuni.2014.10.017
Vermi, 2003, Recruitment of immature plasmacytoid dendritic cells (Plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas, J Pathol., 200, 255, 10.1002/path.1344
Charles, 2010, Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor, J Invest Dermatol., 130, 1646, 10.1038/jid.2010.24
Spranger, 2017, Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy, Cancer Cell, 31, 711, 10.1016/j.ccell.2017.04.003
Dengel, 2010, Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma, J Immunother., 33, 965, 10.1097/CJI.0b013e3181fb045d
Wightman, 2015, Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome, Br J Cancer, 113, 327, 10.1038/bjc.2015.193
Mohty, 2010, Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma, Immunobiology, 215, 113, 10.1016/j.imbio.2009.03.008
Yang, 2017, Insights into Local tumor microenvironment immune factors associated with regression of cutaneous melanoma metastases by mycobacterium bovis Bacille Calmette-Guerin, Front Oncol., 7, 61, 10.3389/fonc.2017.00061
Petro, 2013, Cutaneous tumors cease CXCL9/Mig production as a result of IFN-gamma-mediated immunoediting, J Immunol., 190, 832, 10.4049/jimmunol.1201906
Wennerberg, 2015, CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo, Cancer Immunol Immunother., 64, 225, 10.1007/s00262-014-1629-5
Monteagudo, 2007, CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors, J Clin Pathol., 60, 596, 10.1136/jcp.2005.032144
Jenkins, 2015, CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity, PLoS ONE, 10, e0121140, 10.1371/journal.pone.0121140
Kawada, 2004, Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes, Cancer Res., 64, 4010, 10.1158/0008-5472.CAN-03-1757
Boulday, 2006, Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo, J Immunol., 176, 3098, 10.4049/jimmunol.176.5.3098
Amatschek, 2011, CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells, Br J Cancer, 104, 469, 10.1038/sj.bjc.6606056
Pease, 2017, Designing small molecule CXCR3 antagonists, Expert Opin Drug Discov., 12, 159, 10.1080/17460441.2017.1268597
Kallinich, 2003, Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides, J Invest Dermatol., 121, 1045, 10.1046/j.1523-1747.2003.12555.x
Maliniemi, 2014, Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes, Orphanet J Rare Dis., 9, 160, 10.1186/s13023-014-0160-2
Lu, 2001, The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides, Am J Clin Pathol., 115, 413, 10.1309/3N7P-J84L-JQ9K-G89R
Yagi, 2006, Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay, Am J Surg Pathol., 30, 1111, 10.1097/01.pas.0000213267.92349.59
Winter, 2007, Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients, J Immunol., 179, 4272, 10.4049/jimmunol.179.6.4272
Bendriss-Vermare, 2004, In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response, Leukemia, 18, 1491, 10.1038/sj.leu.2403452
Yamaguchi, 2006, Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders, Br J Dermatol., 154, 904, 10.1111/j.1365-2133.2005.07039.x
Magro, 2016, Epidermotropic B-cell lymphoma: a unique subset of CXCR3-positive marginal zone lymphoma, Am J Dermatopathol., 38, 105, 10.1097/DAD.0000000000000401
Neville, 2007, Management of nonmelanoma skin cancer in 2007, Nat Clin Pract Oncol., 4, 462, 10.1038/ncponc0883
Lindelof, 2000, Incidence of skin cancer in 5356 patients following organ transplantation, Br J Dermatol., 143, 513, 10.1046/j.1365-2133.2000.03703.x
Rangwala, 2011, Roles of the immune system in skin cancer, Br J Dermatol., 165, 953, 10.1111/j.1365-2133.2011.10507.x
Wenzel, 2008, Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin, Int J Cancer, 123, 2605, 10.1002/ijc.23799
Wenzel, , Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod, J Cutan Pathol., 32, 257, 10.1111/j.0303-6987.2005.00297.x
Lo, 2010, CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas, Am J Pathol., 176, 2435, 10.2353/ajpath.2010.081059
Lo, 2011, CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes, Br J Dermatol., 165, 1030, 10.1111/j.1365-2133.2011.10489.x
Winkler, 2011, CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis, Cancer Res., 71, 5707, 10.1158/0008-5472.CAN-11-0907
Kwong, 2010, Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis, J Invest Dermatol., 130, 1726, 10.1038/jid.2009.362
Kuo, 2017, HPV16E7-induced hyperplasia promotes CXCL9/10 expression and induces CXCR3+ T-cell migration to skin, J Invest Dermatol, 138, 1349, 10.1016/j.jid.2017.12.021
Tuong, 2018, Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions, Papillomavirus Res., 5, 6, 10.1016/j.pvr.2017.10.001
Choyce, 2013, Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes, PLoS ONE, 8, e57798, 10.1371/journal.pone.0057798
Jazayeri, 2017, HPV16-E7-specific activated CD8 T cells in E7 transgenic skin and skin grafts, Front Immunol., 8, 524, 10.3389/fimmu.2017.00524
Mattarollo, 2010, Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production, J Immunol., 184, 1242, 10.4049/jimmunol.0902191
Mittal, 2013, Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7, J Invest Dermatol., 133, 2686, 10.1038/jid.2013.222